Your browser doesn't support javascript.
loading
Reconstitution of norovirus-specific T cell responses following hematopoietic stem cell transplantation in patients with inborn errors of immunity and chronic norovirus infection.
Durkee-Shock, Jessica; Cohen, Ariella; Maghzian, Naseem; Pezzella, Gloria; Jensen-Wachspress, Mariah; Hostal, Anna; Barton, Karenna; Gangler, Krista; Dávila Saldaña, Blachy J; Chaimongkol, Natthawan; Bollard, Catherine M; Sosnovtsev, Stanislav V; Cohen, Jeffrey; Nagata, Bianca M; Alves, Derron A; Ghosh, Rajarshi; Seifert, Bryce A; Freeman, Alexandra; Gonzalez, Corina; Notarangelo, Luigi D; Green, Kim Y; Keller, Michael D.
Afiliação
  • Durkee-Shock J; Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Cohen A; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA.
  • Maghzian N; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA.
  • Pezzella G; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA.
  • Jensen-Wachspress M; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA.
  • Hostal A; Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Barton K; Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Gangler K; Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Dávila Saldaña BJ; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA.
  • Chaimongkol N; Division of Blood and Marrow Transplantation, Children's National Hospital, Washington, DC, USA.
  • Bollard CM; Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Sosnovtsev SV; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA.
  • Cohen J; Division of Blood and Marrow Transplantation, Children's National Hospital, Washington, DC, USA.
  • Nagata BM; Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Alves DA; Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Ghosh R; Infectious Disease Pathogenesis Section, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Rockville, MD, USA.
  • Seifert BA; Infectious Disease Pathogenesis Section, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Rockville, MD, USA.
  • Freeman A; NIAID Centralized Sequencing Program, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Gonzalez C; NIAID Centralized Sequencing Program, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Notarangelo LD; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Green KY; Immune Deficiency Cellular Therapy Program, National Cancer Institute, Bethesda, MD, USA.
  • Keller MD; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
J Infect Dis ; 2024 Aug 14.
Article em En | MEDLINE | ID: mdl-39140311
ABSTRACT

BACKGROUND:

Chronic norovirus infection (CNI) causes significant morbidity in immunocompromised patients. No effective prevention or treatment currently exists.

METHODS:

Two patients with inborn errors of immunity, X- linked severe combined immunodeficiency (X-SCID) and DOCK8 deficiency, were followed longitudinally for clinical course, immune reconstitution, norovirus-specific T cell (NST) response, B cell reconstitution, and norovirus-specific antibody production. Samples were obtained in the peri-hematopoietic stem cell transplant setting (HSCT) before and after CNI clearance. The norovirus strain causing CNI was followed longitudinally for norovirus stool viral loads and sequencing.

RESULTS:

The noroviruses were identified as GII.4 Sydney[P4 New Orleans] in one patient and GII.17[P17] in the other. An exacerbation of diarrhea post-HSCT in the patient with X-SCID was consistent with norovirus infection but not with graft-vs-host-disease on pathologic samples. Both patients recovered polyfunctional NSTs in the CD4 and CD8 T cell compartments which recognized multiple norovirus structural and non-structural viral antigens. T cell responses were minimal during active CNI but detectable after resolution. Mapping of norovirus-specific T cell responses between the patient with DOCK8 and his matched sibling donor were nearly identical. B cell reconstitution or new endogenous antibody production for IgA or IgG were not observed.

CONCLUSION:

This report is the first to demonstrate reconstitution of norovirus-specific T cell immunity after HSCT closely temporally aligned with clearance of CNI suggesting that cellular immunity is sufficient for norovirus clearance.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Infect Dis Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Infect Dis Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos